Implications of the findings from the ESMO study of regulatory barriers, cost and availability of anti-cancer agents for European oncologists and pa...

Date 28 September 2014
Event ESMO 2014
Session Availability of anti-neoplastic medicines across Europe: First results of the ESMO-led European Consortium Study
Topics Bioethics, Legal, and Economic Issues
Presenter Alexandru Eniu
Authors A. Eniu
  • -, Ion Chiricuta Oncology Institute, RO-400015 - Cluj Napoca/RO